progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects
Study identifier:4522IL/0044
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Randomized, Double-Blind, multicenter, trial to assess the effect of high & Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.
Medical condition
Carotid Artery Stenosis
Phase
Phase 3
Healthy volunteers
No
Study drug
Rosuvastatin
Sex
All
Actual Enrollment
200
Study type
Interventional
Age
18 Years - 150 Years
Date
Study Start Date: 01 Jan 2000
Primary Completion Date: -
Study Completion Date: 01 Aug 2004
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 | - |
Contacts
Investigators
Principal Investigator
Tom Hatsukami
University of Washington, USA
